Childhood muscular dystrophies

Area of Science:

• Neurology
• Genetics
• Pediatrics

Background:

• Infancy- and childhood-onset muscular dystrophies (MD) are a group of inherited disorders characterized by progressive muscle weakness and degeneration.
• The genetic underpinnings of childhood MD are diverse, affecting proteins integral to muscle cell structure and function.

Approach:

• Diagnosis involves a combination of clinical evaluation, including characteristic muscle weakness patterns and cardiac involvement.
• Biochemical markers such as elevated serum creatine kinase (CK) levels are crucial indicators.
• Histopathological examination of muscle tissue reveals myofiber necrosis and regeneration.
• Advanced molecular neurogenetic assessments, particularly next-generation sequencing (NGS), are essential for identifying causative genes.

Key Points:

• Key diagnostic features include pelvic-femoral and scapular muscle wasting, cardiac myopathy, elevated serum muscle enzymes (e.g., CK), characteristic muscle biopsy findings, and genetic mutations.
• Next-generation sequencing plays a pivotal role in pinpointing specific genetic defects in affected individuals and families.
• While animal models for gene transfer therapies exist, clinical application remains limited.

Conclusions:

• Current therapeutic strategies for childhood muscular dystrophies are primarily symptomatic, aimed at managing motor and cardiorespiratory complications.
• Accurate diagnosis through a multi-faceted approach is critical for understanding disease progression and guiding supportive care.